Related Experiment Videos
NaN/Nav1.9: a sodium channel with unique properties
Sulayman Dib-Hajj1, Joel A Black, Theodore R Cummins
1Department of Neurology and PVA/EPVA Neuroscience Research Center, Yale University School of Medicine, New Haven, CT 06510, USA.
Trends in Neurosciences
|April 26, 2002
Summary
The Nav1.9 sodium channel in pain-sensing neurons is crucial for normal nerve function. Its downregulation after injury may lead to chronic pain, making it a potential therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Pain Research
Background:
- The Nav1.9 sodium channel (NaN) is primarily found in nociceptive neurons within the dorsal root ganglia (DRG) and trigeminal ganglia.
- Nav1.9 generates a persistent, tetrodotoxin-resistant sodium current, characterized by significant overlap between activation and inactivation curves.
- This channel influences the resting membrane potential and amplifies minor depolarizations in primary nociceptive neurons.
Purpose of the Study:
- To investigate the role of Nav1.9 in the electrophysiological properties of primary nociceptive neurons.
- To explore the potential contribution of Nav1.9 downregulation to neuronal hyperexcitability following nerve injury.
- To evaluate Nav1.9 as a potential therapeutic target for pain management.
Main Methods:
- Electrophysiological recordings to characterize Nav1.9 currents.
- Analysis of Nav1.9 expression levels in DRG neurons.
- Investigation of the effects of glial cell-derived neurotrophic factor (GDNF) on Nav1.9 expression and neuronal excitability.
Main Results:
- Nav1.9 exhibits unique properties, including a persistent current and modulation of neuronal resting potential.
- Downregulation of Nav1.9 was observed following peripheral axotomy, linked to reduced GDNF levels.
- This downregulation may contribute to the hyperexcitability of DRG neurons post-nerve injury.
Conclusions:
- Nav1.9 plays a significant role in the excitability of nociceptive neurons and pain signaling.
- Altered Nav1.9 function, particularly its downregulation, is implicated in neuropathic pain mechanisms.
- Targeting Nav1.9 presents a promising strategy for developing novel pain therapies.